Improvement of Vascular Insulin Sensitivity by Ranolazine

Improvement of Vascular Insulin Sensitivity by Ranolazine

Ranolazine (RN) is a drug used in the treatment of chronic coronary ischemia. Different clinical trials have shown that RN behaves as an anti-diabetic drug by lowering blood glucose and glycosylated hemoglobin (HbA1c) levels. However, RN has not been shown to improve insulin (IN) sensitivity. Our st...

Full description

Bibliographic Details
Main Authors: Sol Guerra-Ojeda, Adrian Jorda, Constanza Aldasoro, Jose M. Vila, Soraya L. Valles, Oscar J Arias-Mutis, Martin Aldasoro
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
insulin
ranolazine
nitric oxide
vascular
adrenergic system
Online Access:https://www.mdpi.com/1422-0067/24/17/13532

Internet

https://www.mdpi.com/1422-0067/24/17/13532

Similar Items